In contrast to the studies in Japan, a European study in nine countries found that CagA positivity was associated with a 6.5-fold OR for non-cardia gastric cancer (OR = 6.5, 95% CI: 3.3–12.6) compared to H. pylori-positive CagA seronegative subjects [68]. This evidence concerns the gene S100A8 and gastric cancer.